Healthcare stewards see success on access to vaccines
April 7, 2022
The pandemic has brought the issue of global access into the mainstream for both investors and companies. When AstraZeneca chief executive Pascal Soriot announced the pharmaceutical company’s decision to begin generating profit on its sales of Covid-19 vaccine in November 2021, some may have perceived this as a step backwards for ...
To continue reading
Already a subscriber? Log in
|
Request Free Trial |
Read Next:
Risks emerge from patchwork European sustainability approaches
November 9, 2021
The opportunity for regulatory arbitrage in the EU may lead to further and tighter regulatory intervention The lack of minimum standards backing up asset managers’ sustainable disclosures has created a... Read more
Read more